Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements

European Journal of Neuroscience

Volumn 12, Issue 1, 2000, Pages 337-344

  Vila, M ^a   Perier C ^a   Feger J ^a,b   Yelnik, J ^a   Faucheux, B ^a   Ruberg, M ^a   Raisman Vozari, R ^a   Agid, Y ^a   Hirsch, E C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Faculte de Pharmacie   (France)

Author keywords

6 OHDA lesioned rats; Basal ganglia; Cytochrome oxidase; Electrophysiology; Parkinson's disease; Subthalamic nucleus

Indexed keywords

CYTOCHROME C OXIDASE; MESSENGER RNA; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN INJURY; BRAIN METABOLISM; CONTROLLED STUDY; DENERVATION; ELECTRIC ACTIVITY; IN SITU HYBRIDIZATION; INTOXICATION; MALE; MICROINJECTION; NERVE CELL; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SPIKE WAVE; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

ANIMALS; CARRIER PROTEINS; CORPUS STRIATUM; DENERVATION; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTRON TRANSPORT COMPLEX IV; ELECTROPHYSIOLOGY; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE POTENTIALS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NEURONS; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 0033959548     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.00901.x     Document Type: Article

References (49)

1. Albin, R.L., Young, A.B. & Penney, J.B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci., 12, 366-375.
2. Alexander, G.E. & Crutcher, M.D. (1990) Functional architecture of the basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci, 13, 266-271.
3. + transport in canine brain. Stroke, 12, 726-730.
4. Aziz, T.Z., Peggs, D., Sambrook, M.A. & Crossman, A.R. (1991) Lesions of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov. Disord., 4, 288-292.
5. Benazzouz, A., Gross, C., Féger, J., Boraud, T. & Bioulac, B. (1993) Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur. J. Neurosci., 5, 382-389.
6. Bergman, H., Wichmann, T. & DeLong, M.R. (1990) Reversal of experimental parkinsonism by lesions of the suhthalamic nucleus. Science, 249, 1436-1438.
7. Blanchard, V., Chritin, M, Vyas, S., Savasta, M, Feuerstein, C., Agid, Y., Javoy-Agid. F. & Raisman-Vozari, R. (1995) Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain. J. Neurochem., 64, 1669-1679.
8. Brotchie, J.M., Mitchell, I.J., Sambrook, M.A. & Crossman, A.R. (1991) Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate. Mov. Disord., 6, 133-138.
9. Ganteras, N.S., Shammah-Lagnado, S.J., Silva, B.A. & Ricardo, J.A. (1988) Somatosensory inputs to the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res., 458, 53-64.
10. Chergui, K., Nomikos, G.G., Mathé, J.M., Gonon, F. & Svensson, T.H. (1996) Burst stimulation of the medial forebrain bundle selectively increases Fos immunoreactivity in the limbic forebrain of the rat. Neuroscience, 72, 141-151.
11. Crossman, A.R. (1989) Neural mechanisms in disorders of movement. Comp. Biochem. Physiol., 93, 141-149.
12. DeLong, MR. (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci., 13, 281-285.
13. Erecinska, M. & Silver, I.A. (1989) ATP and brain function. J. Cereb. Blood Flow Metab., 9, 2-19.
14. Féger, J. & Robledo, P. (1992) The effects of activation or inhibition of the subthalamic nucleus on the metabolic and electrophysiological activities within the paludal complex and substantia nigra in the rat. Eur. J. Neurosci., 3, 947-952.
15. Féger, J., Bevan, M. & Crossman, A.R. (1994) The projections from the parafascicular thalamic nucleus to the subthalamic nucleus and the striatum arise from separate neuronal populations: a comparison with the corticostriatal and corticosubthalamic afferents in a retrograde fluorescent double-labelling study. Brain, 60, 125-132.
16. Flores, G., Valencia, J., Resales, M.G., Sierra, A. & Acevas, J. (1993) Appearance of EMG activity and motor asymmetry after unilateral lesions of the dopaminergic innervation to the subthalamic nucleus in the rat. Neurosci. Lett., 162, 153-156.
17. Fontaine, B., Sassoon, D., Buckingham, M. & Changeux, J.P. (1988) Detection of the nicotinic acetylcholine receptor subunit mRNA by in situ hybridization at neuromuscular junction of 15-day-old chick striatal muscles. EMBO J., 7, 603-609.
18. Freed, C., Revay, R., Vaughan, R.A., Kriek, E., Grant, S., Uhl, G.R. & Kuhar, M.J. (1995) Dopamine transporter immunoreactivity in rat brain. J. Comp. Neurol., 359, 340-349.
19. Gonon, F.G. (1988) Non linear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience, 24, 19-28.
20. Graybiel, A.M. & Ragsdale, C.W. (1978) Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylcholinesterase staining. Proc. Natl Acad. Sci. USA, 75, 5723-5726.
21. Greenamyre, J.T., Eller, R.V., Zhang, Z., Ovadia, A., Kurlan, R. & Gash, D.M. (1994) Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease. Ann. Neural., 35, 655-661.
22. Guridi, J., Herrero, M.T., Luquin, M.R., Guillen, J., Ruberg, M., Laguna, J., Vila, M., Javoy-Agid, F., Agid, Y., Hirsch, E.C. & Obeso, J.A. (1996) Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. Brain, 119, 1717-1727.
23. Hassani, O.K., François, C., Yelnik, J. & Féger, J. (1997) Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. Brain Res., 749, 88-94.
24. Hevner, R.F. & Wong-Riley, M.T.T. (1990) Regulation of cytochrome oxidase protein levels by functional activity in the macaque monkey visual system. J. Neurosci., 10, 1331-1340.
25. Hevner, R.F. & Wong-Riley, M.T.T. (1991) Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein. J. Neurosci., 11, 1942-1958.
26. +-ATPase. Neurosci. Lett., 138, 188-192.
27. Joyce, E.M. & Iversen, S.D. (1984) Dissociable effects of 6-OHDA-induced lesions of neostriatum on anorexia, locomotor activity and stereotypy: the role of behavioural competition. Psychopharmacology, 83, 363-366.
28. Kaneoke, Y. & Vitek, J.L. (1996) Burst and oscillation as disparate neuronal properties. J. Neurosci. Meth., 68, 211-223.
29. Klockgether, T. & Turski, L. (1990) NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats. Ann. Neurol., 28, 539-546.
30. Klockgether, T., Turski, L., Honoré, T., Zhang, Z., Gash, D.M., Kurlan, R. & Greenamyre, J.T. (1991) The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine depleted rats and MPTP treated monkeys. Ann. Neurol., 30, 717-723.
31. Limousin, P., Pollak, P., Benazzouz, A., Hoffman, D., Le Bas, J.F., Broussolle, E., Perret, J. & Benabid, A.L. (1995) Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet, 345, 91-95.
32. Lindefors, N., Brene, S. & Persson, H. (1990) Increased expression of glutamic acid decarboxylase in rat substantia nigra after ibotenic acid lesion in the caudate-putamen. Mol. Brain Res., 7, 207-212.
33. Mata, M., Fink, D.J., Gainer, H., Smith, C.B., Davidsen, L., Savaki, H., Schwartz, W.J. & Sokoloff, L. (1980) Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J. Neurochem., 34, 213-215.
34. Mitchell, I.J., Clarke, C.E., Boyce, S., Robertson, R.G., Peggs, D.E., Sambrook, M.A. & Crossman, A.R. (1989) Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience, 32, 213-226.
35. Nakao, N., Ogura, M., Nakai, K. & Itakura, T. (1998) Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease. J. Neurosci., 18, 1806-1817.
36. Naudon, L., Raisman-Vozari, R., Edwards, R.H., Leroux-Nicollet, I., Peter, D., Liu, Y. & Costentin, J. (1996) Reserpine affects differentially the density of the vesicular monoamine transporter and dihydrotetrabenazine binding sites. Eur. J. Neurosci., 8, 842-846.
37. Parry, T.J., Eberlewang, K., Lucki, I. & Chesselet, M.F. (1994) Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats. Exp. Neurol., 128, 181-190.
38. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
39. Porter, R.H.P., Greene, J.G., Higgins, D.S. Jr & Greenamyre, J.T. (1994) Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J. Neurosci., 14, 7192-7199.
40. Schwartz, J., Smith, C.B., Davidsen, L., Savaki, H. & Sokoloff, L. (1979) Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. Science, 205, 723-725.
41. Segovia, J., Tillikaratne, N.J.K., Whelan, K., Tobin, A.J. & Gale, K. (1990) Parallel increases in striatal glutamic acid decarboxylase and mRNA levels in rats with lesions of nigrostriatal pathway. Brain Res., 529, 345-348.
42. Sellal, F., Hirsch, E., Lisovoski, F., Mutschier, V., Collard, M. & Marescaux, C. (1992) Contralateral disappearance of parkinsonian signs after subthalamic hematoma. Neurology, 42, 255-256.
43. Soghomonian, J.J., Pednault, S., Audet, G. & Parent, A. (1994) Increased glutamate decarboxylase mRNA level in the striatum and pallidum of MPTP-treated primates. J. Neurosci., 14, 6256-6265.
44. Vernier, P., Julien, J.F., Rataboul, P., Fourrier, O., Feuerstein, C. & Mallet, J. (1988) Similar time course changes in striatal levels of glutamic acid decarboxylase and proenkephalin mRNA following dopaminergic deafferentation in the rat. J. Neurochem., 51, 1375-1380.
45. Vila, M., Levy, R., Herrero, M.T., Faucheux, B., Obeso, J.A., Agid, Y. & Hirsch, E.C. (1996) Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non human primates: a cytochrome oxidase histochemistry study. Neuroscience, 71, 903-912.
46. Vila, M., Levy, R., Herrero, M.T., Ruberg, M., Faucheux, B., Obeso, J.A., Agid, Y. & Hirsch, E.C. (1997) Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and non-human primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J. Neurosci., 17, 765-773.
47. Vila, M., Marin, C., Ruberg, M., Jimenez, A., Raisman-Vozari, R., Agid, Y., Tolosa, E. & Hirsch, E.C. (1999) Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia. J. Neurochem., 73, 344-352.
48. Wichmann, T. & DeLong, M.R. (1993) Pathophysiology of parkinsonian motor abnormalities. In Narabayashi, H., Nagatsu, T., Yanagisawa, N. & Mizuno, Y. (eds), Advances in Neurology, Vol. 60. Raven Press, New York, pp. 53-61.
49. Wong-Riley, M.T.T. & Carroll, E.W. (1984) Effect of impulse blockage on cytochrome oxidase activity in monkey visual system. Nature, 307, 262-264.